Page last updated: 2024-08-21

treosulfan and Epithelial Ovarian Cancer

treosulfan has been researched along with Epithelial Ovarian Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lane, G; Montes, A; Seshadri, S; Wuntakal, R1

Reviews

1 review(s) available for treosulfan and Epithelial Ovarian Cancer

ArticleYear
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
    The Cochrane database of systematic reviews, 2016, Jun-29, Issue:6

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Busulfan; Carcinoma, Ovarian Epithelial; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Randomized Controlled Trials as Topic

2016